Similar risk of kidney failure among patients with blinding diseases who receive ranibizumab, aflibercept, and bevacizumab: an OHDSI Network Study
Article in Ophthalmology Retina (March 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Article in Ophthalmology Retina (March 2024)
Article in International Urology and Nephrology (March 2024)
Article in International Journal of Clinical Oncology (February 2024)